Related Experiment Video
Updated: Jun 21, 2026

Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
Genetically Predicted Gut Microbiota and Host Metabolites Mediate the Causal Link Between Dietary Factors and Acute
Jiading Qin1,2, Ling Zhang3, Guangcheng Zhang1
1Department of Hematology and Oncology, Shenzhen University General Hospital, International Cancer Center, Hematology Institution, Haoshi Cell Therapy Institute of Shenzhen University, Shenzhen University Medical School Shenzhen University Shenzhen China.
Abstract:
Dietary factors may have a causative influence on acute myeloid leukemia (AML), a hematologic cancer known to be highly fatal. It is still mostly unknown whether causal mechanisms connect dietary exposures to AML, particularly through the gut microbiota and host metabolism. A two-sample Mendelian randomization (MR) analysis was conducted using genome-wide association study (GWAS) data to assess the causal effect of 20 routine dietary factors on AML. A two-step MR framework was employed to assess the mediating roles of gut microbiota and host metabolites. Sensitivity analyses, including inverse variance weighted (IVW), MR-Egger, and MR-PRESSO, were performed to ensure the robustness of results. Processed meat consumption was causally associated with an increased risk of AML (IVW OR = 15.111; 95% CI = 1.253-182.262; p = 0.033). The gut microbiota-associated L-histidine degradation I pathway was identified as a pro-carcinogenic mediator, accounting for 19.5% of the effect. Conversely, host metabolites, including circulating glycerol levels and the free cholesterol-to-total lipids ratio in very large high-density lipoprotein (HDL), functioned as protective mediators. No substantial horizontal pleiotropy or heterogeneity was observed, thereby reinforcing the validity of these findings. This research offers a new understanding of the role of processed meat in the development of AML via the microbiota-metabolite axis and emphasizes possible metabolic compensatory pathways.
Related Concept Videos
Determinants of Bacterial Pathogenicity and Virulence
Inflammatory Bowel Disease III: Crohn's Disease

